Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Conditions:   Paget's Disease of the Bone;   HypocalcemiaIntervention:   Drug: ZOL446Sponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified January 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials